Isolation of Monoclonal Antibodies with Predetermined Conformational Epitope Specificity

DSpace/Manakin Repository

Isolation of Monoclonal Antibodies with Predetermined Conformational Epitope Specificity

Citable link to this page

 

 
Title: Isolation of Monoclonal Antibodies with Predetermined Conformational Epitope Specificity
Author: Essono, Sosthène S.; Shanmuganathan, Vivekanandan; Hemashettar, Girish; Kahn, Maria; Hu, Shiu-Lok; Montefiori, David C.; Polonis, Victoria R.; Sholukh, Anton M.; Mukhtar, Muhammad Mahmood; Humbert, Michael; Watkins, Jennifer D.; Vyas, Hemant Kumar; Schur, Peter Henry; Ruprecht, Ruth Margrit

Note: Order does not necessarily reflect citation order of authors.

Citation: Sholukh, Anton M., Muhammad M. Mukhtar, Michael Humbert, Sosthène S. Essono, Jennifer D. Watkins, Hemant K. Vyas, Vivekanandan Shanmuganathan, Girish Hemashettar, Maria Kahn, Shiu-Lok Hu, David C. Montefiori, Victoria R. Polonis, Peter H. Schur, and Ruth M. Ruprecht. 2012. Isolation of monoclonal antibodies with predetermined conformational epitope specificity. PLoS ONE 7(6): e38943.
Full Text & Related Files:
Abstract: Existing technologies allow isolating antigen-specific monoclonal antibodies (mAbs) from B cells. We devised a direct approach to isolate mAbs with predetermined conformational epitope specificity, using epitope mimetics (mimotopes) that reflect the three-dimensional structure of given antigen subdomains. We performed differential biopanning using bacteriophages encoding random peptide libraries and polyclonal antibodies (Abs) that had been affinity-purified with either native or denatured antigen. This strategy yielded conformational mimotopes. We then generated mimotope-fluorescent protein fusions, which were used as baits to isolate single memory B cells from rhesus monkeys (RMs). To amplify RM immunoglobulin variable regions, we developed RM-specific PCR primers and generated chimeric simian-human mAbs with predicted epitope specificity. We established proof-of-concept of our strategy by isolating mAbs targeting the conformational V3 loop crown of HIV Env; the new mAbs cross-neutralized viruses of different clades. The novel technology allows isolating mAbs from RMs or other hosts given experimental immunogens or infectious agents.
Published Version: doi:10.1371/journal.pone.0038943
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380854/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10445601
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters